SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 199.07-3.4%Nov 20 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: bob zagorin who wrote (28435)3/2/1999 8:57:00 AM
From: Mudcat  Read Replies (1) of 32384
 
Bob, the good news may only be short term in nature. Let me toss out my opinion for discussion. In the short term, getting milestone payments is good but let's remember that Targretin use for breast cancer is suppose to be the drug that Lgnd depends on for survival. In the AHP deal, Lgnd is helping a future competitor develop a drug that will go head to head or might even be better than Targretin in treating breast cancer. Is Lgnd winning one battle by getting milestone payments now only to lose the war five years from now? And yes I do realize that if the AHP drug sells well, that Lgnd still gets a 3 or 6% royalty.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext